Acellular Pertussis Terminated Phase 4 Trials for Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583)

IndicationStatusPhase
DBCOND0031302 (Acellular Pertussis)Terminated4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00544271Immunogenicity, Antibody Persistence and Safety of GSK Biologicals' DTPa (INFANRIX) and dTpa (BOOSTRIX) Vaccines.Prevention